Last updated: 22 July 2019 at 6:40am EST

Frederick Preiss Net Worth




The estimated Net Worth of Frederick Preiss is at least $2.18 Milion dollars as of 14 June 2011. Frederick Preiss owns over 39,419 units of Atricure Inc stock worth over $1,705,971 and over the last 19 years Frederick sold ATRC stock worth over $472,600.

Frederick Preiss ATRC stock SEC Form 4 insiders trading

Frederick has made over 3 trades of the Atricure Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently Frederick exercised 39,419 units of ATRC stock worth $404,833 on 14 June 2011.

The largest trade Frederick's ever made was exercising 39,419 units of Atricure Inc stock on 14 June 2011 worth over $404,833. On average, Frederick trades about 5,014 units every 48 days since 2005. As of 14 June 2011 Frederick still owns at least 63,419 units of Atricure Inc stock.

You can see the complete history of Frederick Preiss stock trades at the bottom of the page.



What's Frederick Preiss's mailing address?

Frederick's mailing address filed with the SEC is 6033 SCHUMACHER PARK DRIVE, , WEST CHESTER, OH, 45069.

Insiders trading at Atricure Inc

Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie... oraz Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.



What does Atricure Inc do?

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.



Complete history of Frederick Preiss stock trades at Atricure Inc

Osoba
Trans.
Transakcja
Łączna cena
Frederick Preiss
Vice President; Operations
Opcja Ćwiczenie $404,833
14 Jun 2011
Frederick Preiss
Vice President; Operations
Sprzedaż $452,200
10 Jun 2011
Frederick Preiss
Vice President; Operations
Sprzedaż $20,400
15 May 2009


Atricure Inc executives and stock owners

Atricure Inc executives and other stock owners filed with the SEC include: